Literature DB >> 34688994

Caffeine consumption and schizophrenia: A highlight on adenosine receptor-independent mechanisms.

Lumei Huang1, Beáta Sperlágh2.   

Abstract

Schizophrenia is a common psychiatric disorder which affects approximately 1% of the population worldwide. However, the complexity of etiology, treatment resistance and side effects induced by current antipsychotics, relapse prevention, and psychosocial rehabilitation are still to be uncovered. Caffeine, as the world's most widely consumed psychoactive drug, plays a crucial role in daily life. Plenty of preclinical and clinical evidence has illustrated that caffeine consumption could have a beneficial effect on schizophrenia. In this review, we firstly summarize the factors associated with the caffeine-induced beneficial effect. Then, a variety of mechanism of actions independent of adenosine receptor signaling will be discussed with an emphasis on the potential contribution of the microbiome-gut-brain axis to provide more possibilities for future therapeutic, prognosis, and social rehabilitation strategy.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34688994     DOI: 10.1016/j.coph.2021.09.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  2 in total

1.  Sugars, Alcohol, and Caffeine Intake From Drinks Among Outpatients With Mental Health Disorders in Greece: A Pilot Study.

Authors:  Xenia A Apostolakopoulou; Lamprini Kontopoulou; Georgios E Karpetas; Georgios Marakis; Eleni Vasara; Ioannis G Katsaras; Zoi Maraki; Ioanna V Papathanasiou; Konstantinos S Bonotis
Journal:  Cureus       Date:  2022-01-24

2.  Caffeine-Induced Acute and Delayed Responses in Cerebral Metabolism of Control and Schizophrenia-Like Wisket Rats.

Authors:  Gyöngyi Horvath; István Kertész; Tamás Nagy; Leatitia Gabriella Adlan; Gabriella Kekesi; Alexandra Büki; Gabor Tuboly; György Trencsényi
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.